Telik is conducting clinical trials of two drug candidates:
TELINTRA® (Ezatiostat HCl, TLK199) and
TELCYTA® (Canfosfamide HCl, TLK286).

Click on the links below for additional information.

TELINTRA®

TELCYTA®
Ovarian Cancer
Non-Small Cell Lung Cancer

What is a Clinical Trial?

TELINTRA® Tablets (Ezatiostat HCl)
Indication Phase 1 Phase 2 Phase 3
Myelodysplastic Syndrome
Chemotherapy-Induced Cytopenia
TELINTRA® IV
Indication Phase 1 Phase 2 Phase 3
Myelodysplastic Syndrome
TELCYTA® (Canfosfamide HCl)
Indication Clinical Trial Phase 1 Phase 2 Phase 3
Ovarian Cancer ASSIST-1
  ASSIST-3 (Carboplatin + TELCYTA)
  ASSIST-5 (Doxil® + TELCYTA)

Non-Small Cell
Lung Cancer
ASSIST-2
Carboplatin + Taxol® + TELCYTA
  Cisplatin + TELCYTA (1st Line)
Colorectal Cancer  
Breast Cancer  

About Clinical Trials
A clinical trial is a research study that is designed to evaluate a new drug or combination of drugs. Clinical studies are conducted in human volunteers and are the basis of our knowledge of new treatments and whether or not they are safe and effective enough for the general public. If the information gathered in clinical trials of a certain drug suggests that the drug may provide a benefit and is safe, the results are submitted to the Food and Drug Administration (FDA) for review. The FDA decides whether or not the drug will be approved for public use.

Participation in a clinical trial may help to answer important scientific questions that ultimately may benefit the care of patients in the future. Becoming involved in a clinical trial may provide exposure to a new drug or therapy that may provide benefit. However, there is no guarantee that an experimental drug will work. In addition, most clinical trials have what is known as a control group that serves as the basis for comparison of the new treatment. Participants are randomly selected to receive either the experimental treatment or the control, which in the case of cancer, is often a drug or treatment that is already approved for the condition.

In addition to how well a therapy works, clinical trials also investigate side effects that may be caused by a new drug. Because the treatment is experimental, side effects are often not predictable or known.

Below is a list of basic pros and cons, but it is by no means a complete list. To learn more about the pros and cons of clinical trials, talk to your doctor.

Pro: A new therapy may provide benefit over available treatments
Con: The new therapy may not work well
Pro: The side effects of the new therapy may be mild compared to available treatments
Con: The side effects of the new therapy may be more severe than the other available treatments
Pro: The participant will get the same quality of care from the physicians and research staff during the course of the study, regardless of which therapy the participant receives
Con: The participant is not able to choose which therapy she will receive
Pro: Participants are followed closely by the research team
Con: Participants may be required to visit their doctor more often and more testing may be needed

There are many web sites that provide detailed information about clinical trial participation. In particular, the National Institute of Health (NIH) Web site, clinicaltrials.gov, provides a wealth of valuable information. To go directly to the NIH Frequently Asked Questions about Clinical Trials page, click here.

Sitemap Contact Legal Notice Telik Home